XML 132 R112.htm IDEA: XBRL DOCUMENT v3.21.1
SHARE-BASED COMPENSATION - Summary (Details)
$ / shares in Units, $ in Thousands
12 Months Ended
Feb. 10, 2020
$ / shares
shares
Feb. 11, 2019
$ / shares
shares
Feb. 12, 2018
$ / shares
shares
Dec. 31, 2020
USD ($)
installment
$ / shares
shares
Dec. 31, 2019
USD ($)
$ / shares
shares
Dec. 31, 2018
USD ($)
$ / shares
shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Number of shares authorized (shares)       10,400,000    
Share-based compensation cost capitalized as part of real estate assets | $       $ 20 $ 66 $ 287
Weighted-Average Grant Date Fair Value            
Unrecognized compensation cost related to nonvested stock awards | $       $ 1,944    
Compensation cost to be recognized over a weighted-average period       2 years 2 months 12 days    
Performance period       3 years    
Vesting rate based on achievement of TSR relative to the NAREIT retail index (as a percent)       33.33%    
Share based Compensation Arrangement by Share based Payment Award Award Vesting Rights Absolute Total Stockholder Return Metrics Percentage       66.66%    
Number of granted annually shares removed as per amendment       200,000    
Vested each year for the first two anniversaries after conclusion of performance period            
Weighted-Average Grant Date Fair Value            
Vesting rate       20.00%    
Executive Officer | Maximum            
Weighted-Average Grant Date Fair Value            
Percentage released stock awards granted       1.00%    
Restricted Common Stock            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Share-based compensation cost | $       $ 2,239 $ 3,396 $ 3,744
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]            
Nonvested, beginning of period (shares)       971,846    
Granted (shares)       1,628,397    
Vested (shares)       (1,052,161)    
Forfeited (shares)       (28,476)    
Nonvested, end of period (shares)       1,519,606 971,846  
Weighted-Average Grant Date Fair Value            
Weighted average grant-date fair value, nonvested, beginning of period (USD per share) | $ / shares       $ 5.16    
Weighted average grant-date fair value, granted (USD per share) | $ / shares       0.86 $ 2.20 $ 4.55
Weighted average grant-date fair value, vested (USD per share) | $ / shares       2.86    
Weighted average grant-date fair value, forfeited (USD per share) | $ / shares       4.67    
Weighted average grant-date fair value, nonvested, ending of period (USD per share) | $ / shares       $ 2.15 $ 5.16  
Total fair value of shares vested | $       $ 951 $ 3,869 $ 2,189
Number of annual installment for awards to vest | installment       4    
Shares            
Granted (shares)       1,628,397    
Forfeited (shares)       (28,476)    
Nonvested, beginning of period (shares)       971,846    
Nonvested, end of period (shares)       1,519,606 971,846  
Weighted average grant-date fair value, granted (USD per share) | $ / shares       $ 0.86 $ 2.20 $ 4.55
Weighted average grant-date fair value, forfeited (USD per share) | $ / shares       $ 4.67    
Total fair value of shares vested       1,052,161    
Weighted average grant-date fair value, nonvested, ending of period (USD per share) | $ / shares       $ 2.15 $ 5.16  
Granted (shares)       1,628,397    
Performance Shares            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]            
Nonvested, beginning of period (shares)       1,766,580    
Granted (shares)       3,408,083 1,103,537 741,977
Vested (shares)       0    
Forfeited (shares)       (3,408,083) (78,934) (663,043)
Nonvested, end of period (shares)       1,103,537 1,766,580  
Weighted-Average Grant Date Fair Value            
Weighted average grant-date fair value, nonvested, beginning of period (USD per share) | $ / shares       $ 2.96    
Weighted average grant-date fair value, granted (USD per share) | $ / shares       0.84 $ 2.40 $ 2.63
Weighted average grant-date fair value, forfeited (USD per share) | $ / shares       0.84 2.63 $ 2.63
Weighted average grant-date fair value, nonvested, ending of period (USD per share) | $ / shares $ 0.84 $ 4.74 $ 4.76 $ 3.16 $ 2.96  
Unrecognized compensation cost related to nonvested stock awards | $       $ 567    
Performance period       3 years    
Total fair value of shares earned       0    
Shares            
Granted (shares)       3,408,083 1,103,537 741,977
Forfeited (shares)       (3,408,083) (78,934) (663,043)
Nonvested, beginning of period (shares)       1,766,580    
Nonvested, end of period (shares)       1,103,537 1,766,580  
Weighted average grant-date fair value, granted (USD per share) | $ / shares       $ 0.84 $ 2.40 $ 2.63
Weighted average grant-date fair value, forfeited (USD per share) | $ / shares       $ 0.84 $ 2.63 $ 2.63
Shares granted in period classified as liabilities (shares)       1,247,098 566,862  
Total fair value of shares vested       0    
Weighted average grant-date fair value, nonvested, ending of period (USD per share) | $ / shares $ 0.84 $ 4.74 $ 4.76 $ 3.16 $ 2.96  
Risk-free interest rate (as a percent) 1.39% 2.54% 2.36%      
Expected share price volatility (as a percent) 57.98% 60.99% 42.02%      
Granted (shares)       3,408,083 1,103,537 741,977
Performance Shares | Vested each year for the first two anniversaries after conclusion of performance period            
Weighted-Average Grant Date Fair Value            
Vesting rate       20.00%    
Performance Shares | Vested at conclusion of performance period            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Share-based compensation cost | $       $ 3,185 $ 1,564 $ 1,364
Share-based compensation expense related to cancellation of the 2020 PSUs | $       $ 2,052    
Weighted-Average Grant Date Fair Value            
Vesting rate       60.00%    
Performance Shares | Remaining percentage after performance period            
Weighted-Average Grant Date Fair Value            
Compensation cost to be recognized over a weighted-average period       1 year 9 months 18 days    
Vesting rate       40.00%    
Performance Shares | Chief Executive Officer            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]            
Granted (shares) 2,131,245 357,800 240,164      
Weighted-Average Grant Date Fair Value            
Weighted average grant-date fair value, nonvested, ending of period (USD per share) | $ / shares $ 0.88 $ 2.45 $ 3.13      
Shares            
Granted (shares) 2,131,245 357,800 240,164      
Weighted average grant-date fair value, nonvested, ending of period (USD per share) | $ / shares $ 0.88 $ 2.45 $ 3.13      
Granted (shares) 2,131,245 357,800 240,164      
Performance Shares | Officer            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]            
Granted (shares) 1,065,463 178,875 120,064      
Weighted-Average Grant Date Fair Value            
Weighted average grant-date fair value, nonvested, ending of period (USD per share) | $ / shares $ 0.75 $ 2.29 $ 1.63      
Shares            
Granted (shares) 1,065,463 178,875 120,064      
Weighted average grant-date fair value, nonvested, ending of period (USD per share) | $ / shares $ 0.75 $ 2.29 $ 1.63      
Granted (shares) 1,065,463 178,875 120,064